Open Accessibility Menu

Coronavirus (COVID-19) Vaccine Update Click here to learn more.

For information about COVID-19 or to view additional resources, please click here.

About GW OB/Gyn

WELCOME TO THE DEPARTMENT OF OBSTETRICS & GYNECOLOGY AT THE GW MEDICAL FACULTY ASSOCIATES

Thank you for choosing the Department of Obstetrics & Gynecology (OB/GYN) at The GW Medical Faculty Associates. We look forward to caring for you, your developing baby, and family during this important time in your life. Our goal is to provide you the utmost in prenatal care.

We are dedicated to providing comprehensive, personalized care through our clinical, academic, research and education missions. We offer superior general obstetrical and specialty care before, during and after your pregnancy at The GW Medical Faculty Associates (GW MFA) and the George Washington University Hospital (GW Hospital).

Our team of expert doctors, nurse practitioners, and certified nurse-midwives provides comprehensive and individualized care to all, both uncomplicated and high-risk pregnancies. Our multi-disciplinary team approach allows for the integration with specialists in maternal and fetal medicine, reproductive medicine, and other specialties, as needed.

Our Care Teams

General OB/GYN Physicians and Nurse Practitioners. Our obstetrics and gynecology specialists and nurse practitioners are dedicated to the full spectrum of health care. We take a personalized approach to your health, whether you need routine gynecologic care, pregnancy care, or care for conditions that require ongoing management and/or surgery.

Midwifery Services - A Collaborative Approach. Our team of certified nurse-midwives specializes in providing low intervention care utilizing evidence-based strategies to promote normal, physiologic childbirth. We believe that collaborative care between midwives and physicians yields the very best outcomes for pregnant people and their babies. Our team offers comprehensive pregnancy, childbirth, and postpartum care in addition to routine gynecologic care.

Maternal Fetal Medicine for High Risk Pregnancy Care. Our Maternal Fetal Medicine program has obstetricians (also called perinatologists) and nurse practitioners who specialize in caring for those with high-risk pregnancies. We care for families who have experienced high-risk pregnancies in the past, people with chronic health conditions, and those who develop unexpected problems during their pregnancies. We are available for consultation and collaboration with your primary care team as needed.

Genetic Counseling Services. Our genetic counselors are trained to assess risk for genetic disorders and birth defects by reviewing your family and medical history. They can identify screening and testing options that are appropriate either before or during pregnancy to help in planning for a healthy baby. Our goal is to be available to all individuals or couples to educate and support them about their options to insure they make informed decisions.

Conveniently Located

Clinical Trials

  • This study is looking at the relationship between sleep and perinatal mood disorders such as depression and anxiety. Participants will wear a wrist monitor like a fit bit for 10 days to help researchers gain information into sleep patterns during pregnancy and postpartum and will answer questionnaires about their mood.
  • Preterm birth is one of the leading causes of neonatal morbidity and mortality. One of the most significant risk factors is a history of a prior spontaneous preterm birth. Intramuscular progesterone is the only FDA approved medication for the prevention of recurrent preterm birth. Vaginal progesterone is not FDA approved for the prevention of recurrent preterm birth, but has been found to beneficial. Given the presence of trials demonstrating efficacy for both intramuscular and vaginal progesterone in the prevention of recurrent preterm birth, but limited information one being more superior to the other, we are performing a trial comparing vaginal progesterone and intramuscular progesterone for the prevention of recurrent spontaneous preterm birth in women with a history of prior spontaneous preterm birth.
  • [This study is no longer recruiting.] The SONATA Study is an FDA-approved clinical study designed to establish the safety and effectiveness of a new, investigational device to reduce heavy menstrual bleeding caused by uterine fibroids. The device, called the SONATA System, targets fibroids rather than treatment or removing the entire uterus. If effective, this device will provide an alternative to hysterectomy that is: incision-free, preserves the uterus, does not require general anesthesia and is an outpatient procedure.
  • Women with twin pregnancy who have a dilated (open) cervix detected on physical exam before 24 weeks are at increased risk for delivering their babies preterm (before 37 weeks gestation). Prematurity is associated with many complications for the babies including respiratory (breathing) problems, bleeding inside of the brain (a form of stroke), increased risk of infection, kidney, temperature and feeding problems. The primary objective of this study is to determine if physical exam indicated cerclage use reduces the incidence of spontaneous PTB in asymptomatic women with twin gestations with cervical dilation diagnosed on pelvic exam before 24 weeks of gestation.
  • Tranexamic acid was shown to significantly reduce risk of mortality when given to women with diagnosed postpartum hemorrhage in the recent Lancet WOMAN Trial.* The purpose of this study is to determine the optimal dose for using tranexamic acid to prevent postpartum hemorrhage during routine cesarean section. Women undergoing cesarean section will be eligible and must not have a history of blood clots or a known clotting condition. *http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31111-X/fulltext
  • In this study, we are developing non-invasive tools to identify early signs of abnormalities of the placental function using arterial spin labeling (ASL) based on fetal MRI. ASL is a particularly attractive method for early and safe monitoring during pregnancy given that ASL is completely non-invasive and does not require contrast agents or exposure to ionizing radiation. Our specific aim is to develop and validate placental perfusion imaging with substantially improved image quality and sensitivity to abnormalities.
  • This study is being performed at Children's National Health System. We are trying to understand how the normal fetus controls blood flow to the different parts of the body such as the lungs and brain. We will measure your baby's blood flow using the same ultrasound approach used by your obstetrician. We will test your baby's control of blood flow by measuring the responses to changes in your (the mom's), levels of oxygen and carbon dioxide. We will make these changes by asking you to breathe extra oxygen for short periods of time. If your obstetrician determines that your pregnancy is uncomplicated, you and your baby are eligible for this study.